Trial site
Mary Crowley Cancer Research
- 27running trials
- 35closed trials
The trials here
What the 63 trials at this site are about, from their registry records.
- Conditions
- Lung cancer30 trials
- Colorectal cancer19 trials
- Ovarian cancer16 trials
- Pancreatic cancer14 trials
- Endometrial cancer12 trials
- Gastric and oesophageal cancer12 trials
- Head and neck cancer11 trials
- Melanoma10 trials
- Prostate cancer10 trials
- Triple-negative breast cancer10 trials
- Sarcoma7 trials
- Metastatic breast cancer5 trials
- and 15 more
- Phase
- Phase 130 trials
- Phase 1/221 trials
- Phase 210 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Completed22 trials
- Recruiting16 trials
- Terminated12 trials
- Active, not recruiting10 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
- BioAtla, Inc.3 trials
- BriaCell Therapeutics Corporation2 trials
- Clasp Therapeutics, Inc.2 trials
- Compass Therapeutics2 trials
- and 48 more
Running trials
Recruiting
Not yet recruiting
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Recruiting
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recruiting
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recruiting
Recruiting
Active, not recruiting
First in Human Study of TORL-3-600 in Participants With Advanced Cancer
Active, not recruiting
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Active, not recruiting
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Active, not recruiting
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Active, not recruiting
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
Active, not recruiting
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Active, not recruiting
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
- Colorectal cancer5 recruiting
- Ovarian cancer5 recruiting
- Pancreatic cancer5 recruiting
- Endometrial cancer4 recruiting
- Gastric and oesophageal cancer3 recruiting
- Head and neck cancer3 recruiting
- Melanoma3 recruiting
- Prostate cancer3 recruiting
- Bladder cancer2 recruiting
- Brain metastases2 recruiting
- Cervical cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Glioblastoma1 recruiting
- Kidney cancer1 recruiting
- Mesothelioma1 recruiting
- Sarcoma1 recruiting
Closed trials
Withdrawn
Completed
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Terminated
Terminated
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Recruiting
Terminated
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Completed
Terminated
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
Completed
Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Completed
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
Terminated
Terminated
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Completed
A Study of PRT2527 in Participants With Advanced Solid Tumors
Completed
Terminated
Recruiting
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Terminated
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1
Completed
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
Completed
Completed
Terminated
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Completed
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Completed
Completed
Completed
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Terminated
Terminated
Completed
Completed
Completed
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
Recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026